Dr. Gutíerrez-Esteinou has more than 20 years of experience in the clinical development of neuropsychiatric and CNS therapies.
Rolando Gutíerrez-Esteinou, M.D., Vice President of Clinical Development and Pharmacovigilance
Dr. Gutíerrez-Esteinou has more than 20 years of experience in the clinical development of neuropsychiatric and CNS therapies. As Vice President of Clinical Development and Pharmacovigilance at Marinus, he will primarily be responsible for the medical leadership of the postpartum depression programs and drug safety. Dr. Gutíerrez-Esteinou was previously Executive Director and Global Clinical Leader, Psychiatry, at Takeda Pharmaceuticals, and Vice President and Global Therapeutic Area Head at Covance Clinical Development Services. He has also held positions at Prostrakan, Inc.; Bristol-Myers Squibb; Novartis Pharmaceuticals; and the Janssen Research Foundation.
Dr. Gutíerrez-Esteinou holds an M.D. from the National Autonomous University of Mexico Medical School, Mexico City, and was a resident and research fellow at Harvard Medical School.